VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
12 hedge funds and large institutions have $22.4M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
9% more funds holding
Funds holding: 11 → 12 (+1)
2% more capital invested
Capital invested by funds: $22.1M → $22.4M (+$369K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$3.36K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.7K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$410 |
| 4 |
Morgan Stanley
New York
|
+$82 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$84.7K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$38K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.8K |
VBIV Hedge Fund Activity: Q2 2015 in Review
12 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q2 2015, worth a combined $22.4M — up 1.7% from $22.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VBIV positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock Investment Management, opening a new position worth an estimated $3.36K. The largest seller was Hudson Bay Capital Management, cutting an estimated $84.7K.
- 12 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q2 2015, up from 11 in Q1 2015.
- Funds reported $22.4M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q2 2015, up 1.7% quarter-over-quarter.
- 2 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q2 2015 and 1 closed out, a net change of +1 holder.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q2 2015 was BlackRock Investment Management, an estimated $3.36K added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q2 2015 was Hudson Bay Capital Management, an estimated $84.7K sold.
Based on aggregated 13F filings for Q2 2015.